Back to Awarded Treatment Trials


Awarded Trial: 03T-388

Grant ID

03T-388

Illness

Schizophrenia

Primary Drug/Intervention

Bezoar Xiexin Tang

Primary Dosage

60mg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Cai

Sample Size

200

Duration of Study Period for Each Subject

6 weeks

Outcome Measurements

PANSS, CGI

Results

There was no significant effect of the test medication over placebo.

Publication

N/A

Link

N/A

PI Name

Hongjiao Cai

Degree

MD

Center

N/A

Institution

Wuhan Dapeng Pharmaceutical Co., Ltd.

Address

152 Yanjiang Avenue

City or Town

Wuhan

State or Province

N/A

Zip or Postal Code

430014

Country

China

Email Address

exploiture@dpyy.com.cn